Search

everythinglearnresearchcommunity

for

Search:↓

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Sex hormones affect brain injury differently in males and females.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Finasteride effectively treats hair loss in transgender men with few side effects.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Finasteride can cause serious emotional side effects; doctors should check patients' mental health history before prescribing.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

The experiment showed that human skin grown in the lab started to form early hair structures when special cell clusters were added.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Higher minoxidil doses in dogs cause faster heart rate, lower blood pressure, and heart issues.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

The new lab-grown skin model is good for testing sunscreen's protection against DNA damage from UV light.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.